Max Nader Lab for Rehabilitation Technologies and Outcomes Research, Center for Bionic Medicine, Shirley Ryan Ability Lab, Chicago, IL.
Max Nader Lab for Rehabilitation Technologies and Outcomes Research, Center for Bionic Medicine, Shirley Ryan Ability Lab, Chicago, IL; University of Applied Sciences, FH AACHEN, Aachen, Germany.
Arch Phys Med Rehabil. 2019 Apr;100(4):638-647. doi: 10.1016/j.apmr.2018.10.001. Epub 2018 Oct 24.
To investigate the postural and metabolic benefits a walker with adjustable elbow support (LifeWalker [LW]) can provide for ambulation in population with impairment. The clinical outcomes from the elbow support walker will be compared with standard rollator (SR) and participants predicate device (PD).
Case-crossover study design.
Clinical laboratory.
Individuals aged between 18 and 85 years using a rollator walker as primary mode of assistance and certified as medically stable by their primary physician. Participants (N=30; 80% women [n=24]) recruited from a convenient sample provided voluntary consent and completed the study.
Not applicable.
The trunk anterior-posterior (AP) sway (during the 10-meter walk test), oxygen consumption (during the 6-minute walk test), the mean forearm load offloaded to the elbow support as percentage of body weight, and mean peak hand grip load (during the 25-meter walk test) were measured.
Ambulating with a LW led to (1) reduced trunk sway in the AP direction [(Z= -2.34, P=.018); (Z= -3.461, P=.001)]; (2) reduced erector spinae muscle activation at the left lumbar L3 level [(Z= -2.71, P=.007); (Z= -1.71, P=.09)]; and (3) improved gait efficiency [(Z= -2.66, P=.008) ; (Z= -2.66, P=.008) ]. Participants offloaded between 39% and 46% of their body weight through the elbow support armrest while ambulating with the LW. Irrespective of the walker used, participants exerted ∼5%-6% of their body weight in gripping the walker handles during walking.
Using the forearm support-based LW led to upright body posture, offloaded portions of body weight from the lower extremity, and improved gait efficiency during ambulation in comparison to the SR and the participants' own PD. Further studies focusing on population-specific benefits are recommended.
研究具有可调节肘部支撑的助行器(LifeWalker [LW])在有功能障碍的人群中步行时的姿势和代谢益处。将比较肘部支撑助行器的临床结果与标准助行架(SR)和参与者预测装置(PD)。
病例交叉研究设计。
临床实验室。
年龄在 18 岁至 85 岁之间的个体,使用助行架作为主要辅助方式,经初级医生认证为身体稳定。从方便样本中招募参与者(N=30;80%为女性[n=24]),自愿同意并完成了研究。
不适用。
躯干前-后(AP)摆动(在 10 米步行测试期间)、耗氧量(在 6 分钟步行测试期间)、卸至肘部支撑的前臂负荷百分比和平均峰值手握负荷(在 25 米步行测试期间)。
使用 LW 助行时,(1)AP 方向的躯干摆动减少[(Z=-2.34,P=.018);(Z=-3.461,P=.001)];(2)左侧腰椎 L3 水平的竖脊肌激活减少[(Z=-2.71,P=.007);(Z=-1.71,P=.09)];(3)步态效率提高[(Z=-2.66,P=.008);(Z=-2.66,P=.008)]。使用 LW 助行时,参与者通过肘部支撑扶手卸下 39%至 46%的体重。无论使用哪种助行器,参与者在行走时都要施加大约 5%-6%的体重在握住助行器手柄上。
与 SR 和参与者自己的 PD 相比,使用基于前臂支撑的 LW 助行时,身体姿势更直立,下肢部分卸荷,步行时步态效率提高。建议进一步研究特定人群的获益。